These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35728876)

  • 41. Roles of beta 2 integrins of rat neutrophils in complement- and oxygen radical-mediated acute inflammatory injury.
    Mulligan MS; Varani J; Warren JS; Till GO; Smith CW; Anderson DC; Todd RF; Ward PA
    J Immunol; 1992 Mar; 148(6):1847-57. PubMed ID: 1347308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression.
    Masu T; Atsukawa M; Nakatsuka K; Shimizu M; Miura D; Arai T; Harimoto H; Kondo C; Kaneko K; Futagami S; Kawamoto C; Takahashi H; Iwakiri K
    PLoS One; 2018; 13(12):e0200664. PubMed ID: 30596643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
    Braster R; O'Toole T; van Egmond M
    Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint.
    Voets E; Paradé M; Lutje Hulsik D; Spijkers S; Janssen W; Rens J; Reinieren-Beeren I; van den Tillaart G; van Duijnhoven S; Driessen L; Habraken M; van Zandvoort P; Kreijtz J; Vink P; van Elsas A; van Eenennaam H
    J Immunother Cancer; 2019 Dec; 7(1):340. PubMed ID: 31801627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tribody [(HER2)
    Oberg HH; Kellner C; Gonnermann D; Sebens S; Bauerschlag D; Gramatzki M; Kabelitz D; Peipp M; Wesch D
    Front Immunol; 2018; 9():814. PubMed ID: 29725336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer.
    Li F; Liu S
    Front Immunol; 2022; 13():1083462. PubMed ID: 36601109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deposition of reactive oxygen metabolites onto and within living tumor cells during neutrophil-mediated antibody-dependent cellular cytotoxicity.
    Cao D; Boxer LA; Petty HR
    J Cell Physiol; 1993 Aug; 156(2):428-36. PubMed ID: 8344997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.
    Boero S; Morabito A; Banelli B; Cardinali B; Dozin B; Lunardi G; Piccioli P; Lastraioli S; Carosio R; Salvi S; Levaggi A; Poggio F; D'Alonzo A; Romani M; Del Mastro L; Poggi A; Pistillo MP
    J Transl Med; 2015 Oct; 13():324. PubMed ID: 26450443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
    Guti E; Regdon Z; Sturniolo I; Kiss A; Kovács K; Demény M; Szöőr Á; Vereb G; Szöllősi J; Hegedűs C; Polgár Z; Virág L
    Cancer Immunol Immunother; 2022 Sep; 71(9):2151-2168. PubMed ID: 35066605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds.
    Guti E; Bede ÁM; Váróczy C; Hegedűs C; Demény MÁ; Virág L
    J Vis Exp; 2023 Aug; (198):. PubMed ID: 37607075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer.
    Emmons TR; Giridharan T; Singel KL; Khan ANH; Ricciuti J; Howard K; Silva-Del Toro SL; Debreceni IL; Aarts CEM; Brouwer MC; Suzuki S; Kuijpers TW; Jongerius I; Allen LH; Ferreira VP; Schubart A; Sellner H; Eder J; Holland SM; Ram S; Lederer JA; Eng KH; Moysich KB; Odunsi K; Yaffe MB; Zsiros E; Segal BH
    Cancer Immunol Res; 2021 Jul; 9(7):790-810. PubMed ID: 33990375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer.
    Ustyanovska Avtenyuk N; Visser N; Bremer E; Wiersma VR
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines.
    Collins DM; O'Donovan N; McGowan PM; O'Sullivan F; Duffy MJ; Crown J
    Ann Oncol; 2012 Jul; 23(7):1788-95. PubMed ID: 22056974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of corticosteroids on neutrophil function: inhibition of antibody-dependent cell mediated cytotoxicity (ADCC).
    Capsoni F; Meroni PL; Zocchi MR; Plebani AM; Vezio M
    J Immunopharmacol; 1983; 5(3):217-30. PubMed ID: 6655253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis.
    Laengle J; Kabiljo J; Hunter L; Homola J; Prodinger S; Egger G; Bergmann M
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31940587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy.
    Hubert P; Heitzmann A; Viel S; Nicolas A; Sastre-Garau X; Oppezzo P; Pritsch O; Osinaga E; Amigorena S
    Cancer Res; 2011 Aug; 71(15):5134-43. PubMed ID: 21697279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity.
    Horner H; Frank C; Dechant C; Repp R; Glennie M; Herrmann M; Stockmeyer B
    J Immunol; 2007 Jul; 179(1):337-45. PubMed ID: 17579054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C-Reactive Protein Enhances IgG-Mediated Cellular Destruction Through IgG-Fc Receptors
    Temming AR; Tammes Buirs M; Bentlage AEH; Treffers LW; Feringa H; de Taeye SW; Kuijpers TW; Nagelkerke SQ; Brasser G; Mok JY; van Esch WJE; van den Berg TK; Rispens T; van der Schoot CE; Vidarsson G
    Front Immunol; 2021; 12():594773. PubMed ID: 33790888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of leukocyte inhibitory factor (LIF) on neutrophil mediated antibody-dependent cellular cytotoxicity.
    Borish L; Rocklin R
    J Immunol; 1987 Mar; 138(5):1480-4. PubMed ID: 3027180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells.
    Martínez-Sanz P; Hoogendijk AJ; Verkuijlen PJJH; Schornagel K; van Bruggen R; van den Berg TK; Tytgat GAM; Franke K; Kuijpers TW; Matlung HL
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.